Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Four Conversations RCT
Four Conversations Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Four Conversations RCT
Four Conversations Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Promotora Navigator - Culturally Appropriate Patient Navigator
Assessing the Impact of a Community Health Worker on Hispanic Women's Reported Measures of Processes of Care in the Screening Mammography Setting
Status: Enrolling
Updated:  12/31/1969
Matthew Walker Comprehensive Health Center
mi
from
Nashville, TN
Promotora Navigator - Culturally Appropriate Patient Navigator
Assessing the Impact of a Community Health Worker on Hispanic Women's Reported Measures of Processes of Care in the Screening Mammography Setting
Status: Enrolling
Updated: 12/31/1969
Matthew Walker Comprehensive Health Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated:  12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Sedona, AZ
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Sedona, AZ
Click here to add this to my saved trials
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated:  12/31/1969
Pacific Shores Medical Group SC
mi
from
Long Beach, CA
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated: 12/31/1969
Pacific Shores Medical Group SC
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated:  12/31/1969
Oncology Speciialists of Charlotte
mi
from
Charlotte, NC
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated: 12/31/1969
Oncology Speciialists of Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated:  12/31/1969
McLeod Center for Cancer Treatment and Research
mi
from
Florence, SC
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated: 12/31/1969
McLeod Center for Cancer Treatment and Research
mi
from
Florence, SC
Click here to add this to my saved trials
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated:  12/31/1969
Carolina Blood and Cancer Care of South Carolina
mi
from
Rock Hill, SC
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated: 12/31/1969
Carolina Blood and Cancer Care of South Carolina
mi
from
Rock Hill, SC
Click here to add this to my saved trials
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated:  12/31/1969
PeaceHealth St. Joseph Medical Center
mi
from
Bellingham, WA
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Status: Enrolling
Updated: 12/31/1969
PeaceHealth St. Joseph Medical Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
A Phase 1, Randomized, Open-Label, Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (SNDX-275-0141, MK3475-460/KEYNOTE-460)
Status: Enrolling
Updated:  12/31/1969
The START Center for Cancer Care
mi
from
San Antonio, TX
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
A Phase 1, Randomized, Open-Label, Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (SNDX-275-0141, MK3475-460/KEYNOTE-460)
Status: Enrolling
Updated: 12/31/1969
The START Center for Cancer Care
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
The Effects of a Sensorimotor Rehabilitation Program on the Upper and Lower Limbs of Persons With Cancer Following Taxane-Based Chemotherapy for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
The Effects of a Sensorimotor Rehabilitation Program on the Upper and Lower Limbs of Persons With Cancer Following Taxane-Based Chemotherapy for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors
A Randomized Controlled Trial, Using a Mail and Video-based Weight Loss Program for Overweight or Obese Stage I-IIIC Breast Cancer Survivors.
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors
A Randomized Controlled Trial, Using a Mail and Video-based Weight Loss Program for Overweight or Obese Stage I-IIIC Breast Cancer Survivors.
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors
Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Mount Mary University
mi
from
Milwaukee, WI
Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors
Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Mount Mary University
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
Status: Enrolling
Updated:  12/31/1969
International HealthCare, LLC
mi
from
Norwalk, CT
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
Status: Enrolling
Updated: 12/31/1969
International HealthCare, LLC
mi
from
Norwalk, CT
Click here to add this to my saved trials
Stress and Immunity Breast Cancer Project
Psychological/Immunity Studies With Women With Cancer Previously
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Stress and Immunity Breast Cancer Project
Psychological/Immunity Studies With Women With Cancer Previously
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Desert Hematology Oncology Medical Group, Inc
mi
from
Rancho Mirage, CA
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Desert Hematology Oncology Medical Group, Inc
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Stockton Hematology Oncology
mi
from
Stockton, CA
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Stockton Hematology Oncology
mi
from
Stockton, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Louisville Oncology Clinical Research Program
mi
from
Louisville, KY
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Louisville Oncology Clinical Research Program
mi
from
Louisville, KY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Pharma Resource
mi
from
East Providence, RI
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Pharma Resource
mi
from
East Providence, RI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
University of Virginia Health System
mi
from
Charlottesville, VA
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated:  12/31/1969
Institut Jules Bordet
mi
from
Bruxelles,
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment
Status: Enrolling
Updated: 12/31/1969
Institut Jules Bordet
mi
from
Bruxelles,
Click here to add this to my saved trials
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
LCCC 1642: Plasma Circulating Tumor DNA (ctDNA) Analyses in ER+ Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill Cancer Hospital
mi
from
Chapel Hill, NC
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
LCCC 1642: Plasma Circulating Tumor DNA (ctDNA) Analyses in ER+ Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill Cancer Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing
A Feature Comparison Study to Evaluate the Modified Processing of Fujifilm's ASPIRE Cristalle With Digital Breast Tomosynthesis Option as Compared to the Original Processing
Status: Enrolling
Updated:  12/31/1969
International HealthCare, LLC
mi
from
Norwalk, CT
Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing
A Feature Comparison Study to Evaluate the Modified Processing of Fujifilm's ASPIRE Cristalle With Digital Breast Tomosynthesis Option as Compared to the Original Processing
Status: Enrolling
Updated: 12/31/1969
International HealthCare, LLC
mi
from
Norwalk, CT
Click here to add this to my saved trials
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Portland, OR
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Temple, TX
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Hatha Yoga in Breast Cancer Survivors
Feasibility and Preliminary Efficacy of Hatha Yoga in Breast Cancer Survivors: Pilot Study
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University School of Nursing
mi
from
Nashville, TN
Hatha Yoga in Breast Cancer Survivors
Feasibility and Preliminary Efficacy of Hatha Yoga in Breast Cancer Survivors: Pilot Study
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University School of Nursing
mi
from
Nashville, TN
Click here to add this to my saved trials
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
Understanding Barriers to Initiation and Adherence to Adjuvant Endocrine Therapy in Young Breast Cancer Survivors of Diverse Racial, Ethnic, and Socio-economic Backgrounds: The EMPOWER Study
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
Understanding Barriers to Initiation and Adherence to Adjuvant Endocrine Therapy in Young Breast Cancer Survivors of Diverse Racial, Ethnic, and Socio-economic Backgrounds: The EMPOWER Study
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Alta Bates Summit Medical Center
mi
from
Berkeley, CA
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Alta Bates Summit Medical Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Porter Adventist Hospital
mi
from
Denver, CO
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Walter Reed Army Medical Center
mi
from
Washington,
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Boca Raton Community Hospital
mi
from
Boca Raton, FL
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Boca Raton Community Hospital
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Medical Center
mi
from
Springfield, IL
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Charles M. Barrett Cancer Center at University Hospital
mi
from
Cincinnati, OH
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Charles M. Barrett Cancer Center at University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Abramson Cancer Center of the University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials